Page last updated: 2024-08-24

kasugamycin and rifampin

kasugamycin has been researched along with rifampin in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adachi, Y; Kawamura, F; Kim, JY; Masuda, K; Nanamiya, H; Ochi, K; Okamoto, S; Tanaka, Y; Tokuyama, S; Wang, G1
Deaves, JK; Maguire, BA; Wild, DG1
Chaudhuri, S; Chen, Y; Chen, YX; Dartois, VA; Gardner, M; Javid, B; Kawaji, Q; Li, L; Li, YY; Martinot, AJ; Pan, M; Rubin, EJ; Su, HW; Toosky, MN; Zhu, JH; Zimmerman, M1

Other Studies

3 other study(ies) available for kasugamycin and rifampin

ArticleYear
Inactivation of KsgA, a 16S rRNA methyltransferase, causes vigorous emergence of mutants with high-level kasugamycin resistance.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:1

    Topics: Aminoglycosides; Bacillus subtilis; Bacterial Proteins; Drug Resistance, Microbial; Methyltransferases; Mutation; RNA, Ribosomal, 16S

2009
Some properties of two erythromycin-dependent strains of Escherichia coli.
    Journal of general microbiology, 1989, Volume: 135, Issue:3

    Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; Chloramphenicol; Culture Media; DNA, Bacterial; Erythromycin; Escherichia coli; Phenotype; Rifampin; RNA, Bacterial; Spectinomycin; Tetracycline

1989
Kasugamycin potentiates rifampicin and limits emergence of resistance in
    eLife, 2018, 08-28, Volume: 7

    Topics: Aminoacylation; Aminoglycosides; Animals; Drug Resistance, Bacterial; Drug Synergism; Edeine; Injections, Intraperitoneal; Mice; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Organ Specificity; Protein Biosynthesis; Rifampin; RNA, Transfer; Streptomycin; Tuberculosis

2018